Louise E. Hogan

ORCID: 0000-0001-5526-954X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • HIV Research and Treatment
  • Immune Cell Function and Interaction
  • Cytomegalovirus and herpesvirus research
  • HIV/AIDS drug development and treatment
  • HIV/AIDS Research and Interventions
  • Viral-associated cancers and disorders
  • HIV-related health complications and treatments
  • T-cell and B-cell Immunology
  • Fungal Infections and Studies
  • Antifungal resistance and susceptibility
  • Renal Transplantation Outcomes and Treatments
  • Food Security and Health in Diverse Populations
  • Immune Response and Inflammation
  • Themes in Literature Analysis
  • CRISPR and Genetic Engineering
  • CAR-T cell therapy research
  • Blood groups and transfusion
  • Reproductive System and Pregnancy
  • Immunotherapy and Immune Responses
  • T-cell and Retrovirus Studies
  • Glycosylation and Glycoproteins Research
  • Glioma Diagnosis and Treatment
  • Parvovirus B19 Infection Studies
  • Myasthenia Gravis and Thymoma
  • Lymphoma Diagnosis and Treatment

University of California, San Francisco
2015-2021

Harvard University
2017-2018

Brigham and Women's Hospital
2015-2018

City College of San Francisco
2017

St George's, University of London
2012-2016

University of Nottingham
2015

Animal and Plant Health Agency
2012

Background It is unknown if extremely early initiation of antiretroviral therapy (ART) may lead to long-term ART-free HIV remission or cure. As a result, we studied 2 individuals recruited from pre-exposure prophylaxis (PrEP) program who started prophylactic ART an estimated 10 days (Participant A; 54-year-old male) and 12 B; 31-year-old after infection with peak plasma RNA 220 copies/mL 3,343 copies/mL, respectively. Extensive testing blood tissue for persistence was performed, PrEP...

10.1371/journal.pmed.1002417 article EN public-domain PLoS Medicine 2017-11-07

Understanding the host immune response during cryptococcal meningitis (CM) is of critical importance for development immunomodulatory therapies. We profiled cerebrospinal fluid (CSF) immune-response in ninety patients with HIV-associated CM, and examined associations between phenotype clinical outcome. CSF cytokine, chemokine, macrophage activation marker concentrations were assayed at disease presentation, these parameters microbiological outcomes using principal component analysis (PCA)....

10.1371/journal.ppat.1004754 article EN cc-by PLoS Pathogens 2015-04-08

HIV-1-infected cells persist indefinitely despite the use of combination antiretroviral therapy (ART), and novel therapeutic strategies to target purge residual infected in individuals on ART are urgently needed. Here, we demonstrate that CD4+ T cell-associated HIV-1 RNA is often highly enriched expressing CD30, this marker considerably contribute total pool transcriptionally active lymphocytes suppressive ART. Using situ hybridization studies, show co-localization CD30 with transcriptional...

10.1371/journal.ppat.1006856 article EN cc-by PLoS Pathogens 2018-02-22

Systemic chemotherapies for various malignancies have been shown to significantly, yet transiently, decrease numbers of CD4+ T lymphocytes, a major reservoir human immunodeficiency virus type 1 (HIV-1) infection. However, little is known about the impact cytoreductive chemotherapy on HIV-1 dynamics, persistence, and immune responses.We investigated changes in peripheral T-cell-associated DNA RNA levels, lymphocyte activation, viral population structure, virus-specific responses longitudinal...

10.1093/infdis/jix265 article EN The Journal of Infectious Diseases 2017-05-31

Abstract Antigen presenting cells (APC) are critical components of innate immunity and consequently shape the adaptive response. Leukocyte Ig Like Receptors (LILR) immune receptors predominantly expressed on myeloid cells. LILR can influence antigen phenotype monocytic to determine nature T cell responses in infections including Mycobaterium leprae . We therefore investigated relevance context Mycobacterium tuberculosis Real-time PCR studies indicated that transcriptional profile orphan...

10.1038/srep21780 article EN cc-by Scientific Reports 2016-02-24

Pharmacologic inhibition of the mammalian target rapamycin (mTOR) in setting renal transplantation has previously been associated with lower human immunodeficiency virus 1 (HIV-1) DNA burden, and vitro studies suggest that mTOR may lead to HIV transcriptional silencing. Because prospective clinical trials are lacking, we conducted an open-label, single-arm study determine impact broad inhibitor, everolimus, on residual gene expression profiles, immune responses HIV-infected adult solid organ...

10.1111/ajt.16244 article EN cc-by-nc-nd American Journal of Transplantation 2020-08-12

An ability to activate latent HIV-1 expression could benefit many HIV cure strategies, but the first generation of latency reversing agents (LRAs) has proven disappointing. We evaluated AKT/mTOR activators as a potential new class LRAs. Two glycogen synthase kinase-3 inhibitors (GSK-3i's), SB-216763 and tideglusib (the latter already in phase II clinical trials) that signaling were tested. These GSK-3i's reactivated present blood samples from aviremic individuals on antiretroviral therapy...

10.1128/jvi.02393-20 article EN Journal of Virology 2021-02-03

Persistent tissue reservoirs of HIV present a major barrier to cure. Defining subsets infected cells in tissues is focus cure research. Herein, we describe novel multiplexed situ hybridization (ISH) (RNAscope) protocol detect HIV-DNA (vDNA) and HIV-RNA (vRNA) formalin-fixed paraffin-embedded (FFPE) human combination with immunofluorescence (IF) phenotyping the cells. We show that IF ISH (mIFISH) suitable for quantitative assessment vRNA vDNA multiparameter allows precise identification...

10.1369/0022155418756848 article EN Journal of Histochemistry & Cytochemistry 2018-02-20

Leukocyte Immunoglobulin-like receptors (LILR) are innate immune involved in regulating both and adaptive functions. LILR show more interspecies conservation than the closely related Killer Ig-like receptors, homologues have been identified rodents, primates, seals chickens. The murine equivalents, paired (PIR), contain two additional immunoglobulin domains, but strong sequence functional similarities to human LILR. bovine genome was recently sequenced, with preliminary annotations...

10.1371/journal.pone.0034291 article EN cc-by PLoS ONE 2012-04-02

Identifying biomarkers for cells harboring replication-competent HIV is a major research priority. Recently, there have been mixed reports addressing the possibility that CD32-expressing T are enriched HIV. There growing evidence CD32 expression increases with cellular activation may be related to, but not necessarily specific for, infection However, relationship of to HIV-infection in subtypes tissue-resident leukocytes unclear.First, we used duplex chromogenic situ hybridization identify...

10.20411/pai.v4i1.271 article EN cc-by Pathogens and Immunity 2019-05-03

Abstract Background Elite controllers (EC), a small subset of the HIV-positive population (< 1%), suppress HIV viremia below limit quantification clinical viral load assays in absence antiretroviral therapy (ART). However, there is paucity longitudinal data detailing and immune dynamics or reservoir seeding during acute infection individuals that go on to become Controllers. Case presentation In this report, we describe case 42 year old woman diagnosed who rapidly permanently suppressed...

10.1186/s12879-019-4374-8 article EN cc-by BMC Infectious Diseases 2019-09-18

Background.Vitamin D deficiency is associated with impaired immune responses and increased susceptibility to a number of intracellular pathogens in individuals infected human immunodeficiency virus (HIV).It not known whether such an association exists Cryptococcus neoformans.Methods.Levels 25-hydroxyvitamin (25[OH]D) were measured 150 patients cryptococcal meningitis (CM) HIV-infected controls Cape Town, South Africa, associations between vitamin CM examined.The levels notifications analyzed...

10.1093/cid/ciu349 article EN Clinical Infectious Diseases 2014-05-13

Human Herpes Virus 8 (HHV8) can cause Kaposi's Sarcoma (KS) in immunosuppressed individuals. However, little is known about the association between chemotherapy or hematopoietic stem cell transplantation (HSCT), circulating HHV8 DNA levels, and clinical KS HIV-1-infected individuals with various malignancies. Therefore, we examined associations malignancies, systemic cancer chemotherapy, T phenotypes, 29 participants concomitant other diagnoses.We quantified plasma viral loads...

10.1371/journal.pone.0197298 article EN cc-by PLoS ONE 2018-05-10

A revised version of Table S1 with additional information can be viewed here: Click here for data file.(479K, tif) [^]

10.1371/annotation/cfb0e8b5-3815-46c1-997b-c6267ba4856b article EN cc-by PLoS ONE 2012-08-08

10.1097/00000446-191605000-00033 article EN AJN American Journal of Nursing 1916-05-01

10.1177/002205749905000311 article EN Journal of Education 1899-07-01

10.1177/002205749905000812 article EN Journal of Education 1899-08-01

10.1177/002205749905000510 article EN Journal of Education 1899-07-01
Coming Soon ...